Posted on by ScienceFather
55 / 100
Powered by Rank Math SEO

Dr. Vaishali Sanchorawala | Medicine | Women Researcher Award

Dr. Vaishali Sanchorawala, Boston Medical Center, United States

Dr. Vaishali Sanchorawala is a distinguished physician specializing in hematology and oncology, renowned for her expertise in plasma cell dyscrasia, multiple myeloma, and AL amyloidosis. With extensive training from prestigious institutions like Boston University Medical Center and a track record of board certifications and awards, including the Boston Magazine Annual Top Doc recognition multiple times, she exemplifies excellence in clinical care and research. As a compassionate caregiver and mentor, she has received accolades such as the Compassionate Caregiver Award and the Research Mentoring Award nomination. Dr. Sanchorawala’s contributions to medicine and patient care are widely celebrated. 🏥👩‍⚕️🏆

Publication Profile:

Scopus

Orcid

Education:

Dr. Vaishali Sanchorawala pursued her medical education at Seth G.S. Medical College, Bombay University, India, from 1982 to 1988. There, she dedicated herself to the rigorous curriculum, culminating in the attainment of her M.B.B.S. (Bachelor of Medicine and Bachelor of Surgery) degree. This foundational period instilled in her a profound understanding of medical principles and practices, laying the groundwork for her illustrious career in medicine. 🎓Throughout her studies, Dr. Sanchorawala exhibited a keen intellect and a passion for healing, distinguishing herself among her peers. The rich educational environment of Seth G.S. Medical College provided her with invaluable clinical experiences and mentorship, shaping her into the compassionate and skilled physician she is today. 🏥

Certification:

Dr. Vaishali Sanchorawala’s dedication to excellence is evident through her numerous certifications and recertifications. She obtained board certifications in Internal Medicine in 1994, followed by Medical Oncology and Hematology in 1997. Over the years, she has diligently maintained her expertise, undergoing recertifications in Internal Medicine in 2004, 2015, and in Medical Oncology and Hematology in 2007 and 2017, respectively. These ongoing commitments reflect her unwavering pursuit of mastery in her field, ensuring patients receive the highest standard of care. 📜👩‍⚕️

Awards and Honors:

Dr. Vaishali Sanchorawala’s illustrious career is adorned with a plethora of prestigious awards and honors, underscoring her exceptional contributions to medicine and compassionate patient care. From her early achievement of a Gold Medal in Higher Secondary School Certification in 1982 to being recognized as the Woman of the Year 2021 by India New England, she has consistently garnered accolades. Noteworthy honors include the Mortimer M. Bortin Award in 2000, Boston Magazine’s Annual Top Doc recognition in consecutive years, and induction into the Boston University Medical Group’s Clinical Excellence Society for her exemplary leadership. These accolades reflect her unwavering commitment to excellence and service in healthcare. 🏅👩‍⚕️

Training and Teaching Experience:

Dr. Vaishali Sanchorawala’s commitment to training and teaching is evident through her extensive experience as a clinical instructor and preceptor. Since 1997, she has been actively involved in guiding fellows, residents, and students in both outpatient and inpatient settings, providing direct patient care and imparting invaluable clinical knowledge. Her dedication extends to medical education at Boston University School of Medicine, where she has taught courses on various aspects of hematology and oncology, including myeloma and related disorders. Dr. Sanchorawala’s passion for teaching, coupled with her expertise in patient care, makes her an invaluable mentor and educator in the medical field. 📚👩‍🏫

Research Focus:

Dr. Vaishali Sanchorawala’s research focus encompasses a wide array of aspects within hematology, particularly in the realm of amyloidosis. She has made significant contributions to understanding and treating various forms of amyloidosis, including light-chain amyloidosis (AL amyloidosis) and hereditary transthyretin amyloidosis (ATTR). Her work delves into predictive factors for treatment response and survival outcomes, as well as exploring novel biomarkers for polyneuropathy in hereditary transthyretin amyloidosis. Through her research endeavors, Dr. Sanchorawala strives to improve patient outcomes and enhance our understanding of these complex diseases. 🧬🔬

Publication Top Notes :

Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis

Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis

Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial

Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions

Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre

Evaluating the Amyloidosis Speakers Bureau: the influence of amyloidosis patients’ narratives on medical students’ knowledge, attitudes, and behavioral intent

Eureka Moment—Innovation Comes of an Age in Light Chain Amyloidosis

Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group

Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician’s choice

Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report

Vaishali Sanchorawala | Medicine | Women Researcher Award

You May Also Like